Berger J, Molzer B, Faé I, Bernheimer H
Clinical Institute of Neurology, University of Vienna, Austria.
Biochem Biophys Res Commun. 1994 Dec 30;205(3):1638-43. doi: 10.1006/bbrc.1994.2855.
Fragments of the adrenoleukodystrophy (ALD) cDNA from a patient with adolescent ALD were amplified by polymerase chain reaction and subcloned. Bidirectional sequencing of the entire coding ALD gene disclosed a cytosine to guanine transversion at nucleotide 1451 in exon five, resulting in substitution of proline 484 by arginine. Five of nine siblings of the patient, comprising two cerebral ALD, one adrenomyeloneuropathy, one Addison only as well as the symptomatic mother (all accumulating very long chain fatty acids) carried this mutation, which was not found in the unaffected persons, in five unrelated ALD patients, and in twenty controls. We propose that this missense mutation generated the disease per se as well as the metabolic defect; the different phenotypes, however, must have originated by means of additional pathogenetic factors.
通过聚合酶链反应扩增来自一名青少年肾上腺脑白质营养不良(ALD)患者的ALD互补DNA(cDNA)片段,并进行亚克隆。对整个编码ALD基因进行双向测序,发现在外显子5的核苷酸1451处发生了胞嘧啶到鸟嘌呤的颠换,导致脯氨酸484被精氨酸取代。该患者的九个兄弟姐妹中有五个携带此突变,包括两名脑型ALD患者、一名肾上腺脊髓神经病患者、一名仅患艾迪生病的患者以及有症状的母亲(均累积极长链脂肪酸),而在未患病的个体、五名无关的ALD患者以及二十名对照中未发现该突变。我们认为,这种错义突变导致了疾病本身以及代谢缺陷;然而,不同的表型必定是由其他致病因素引起的。